Skip to main content

Firm (s)

Deal

Value

Client

Lead lawyer(s)

Chen & Co

Initial public offering of Shanghai Fosun Pharmaceutical Group Co Ltd

$509 million

Shanghai Fosun Pharmaceutical Group Co Ltd

 

 Haoxiong Jiang,
Spring Qin Zhang and
Jie Cheng

Clifford Chance

 

Global medium-term note programme establishment of SK Telecom, and a subsequent issuance of notes under the programme

$700 million

1.Barclays

2.BofA Merrill Lynch

3.Credit Suisse

4.Deutsche Bank

5.HSBC

6.UBS

 

Hyun Kim

Clifford Chance

Global medium-term note programme establishment of NongHyup Bank, and a subsequent issuance of notes under the programme

$500 million

1.BNP Paribas

2.Crédit Agricole CIB

3.HSBC

4.Morgan Stanley

5.UBS

 

Hyun Kim and Matt Fairclough

Clifford Chance

 

Global medium-term note programme establishment of Korea Hydro & Nuclear Power Co, and a subsequent issuance of notes under the programme

$750 million

1.Citigroup Global Markets Inc

2.Deutsche Bank AG (SG branch)

3.Goldman Sachs International

4.Merrill Lynch International

5.Samsung Securities Co Ltd

 

Hyun Kim

Clifford Chance

Ten-year bancassurance agreement with Allianz SE (Singapore) to distribute Allianz life insurance products across Asia

 

$128.5 million

HSBC

Alex Erasmus and Amy Ho

Clifford Chance

 

SK Telecom’s block trade of Posco shares

$400 million

Morgan Stanley

Hyun Kim

Grandall Law Firm

Initial public offering of Shanghai Fosun Pharmaceutical Group Co Ltd

 

$509 million

1.UBS AG

2.China International Capital Corporation

3.J.P. Morgan Securities (Asia Pacific) Ltd

4.Deutsche Bank AG

5.Agricultural Bank of China International

6.Haitong International

 

 

Herbert Smith Freehills

 

Initial public offering of Shanghai Fosun Pharmaceutical Group Co Ltd

$509 million

1.UBS AG

2.China International Capital Corporation

3.J.P. Morgan Securities (Asia Pacific) Ltd

4.Deutsche Bank AG

5.Agricultural Bank of China International

6.Haitong International

 

Gary Lock and Kevin Roy

Morrison & Foerster

Initial public offering of Shanghai Fosun Pharmaceutical Group Co. Ltd

 

$509 million

Shanghai Fosun Pharmaceutical Group Co Ltd

Gregory Wang, Ven Tan and John Moore

 Where exact value is not known, ALB will use an approximate value based on available market data or coverage.

 

 

Follow us on Twitter: @ALB_Magazine.

Related Articles

报名开始:2025 ALB China十五佳出海业务律师 / Submission open: 2025 ALB China Top 15 Overseas Investment Lawyers

ALB聚焦于企业出海尤其是律师在助力企业的出海中的重要角色,于2025年推出首个出海业务律师榜单——2025 ALB China十五佳出海业务律师。

2024 ALB China天达共和十五佳总法律顾问圆桌会议成功举办 (ZH/EN)

10月18日,2024 ALB天达共和十五佳总法律顾问圆桌会议在北京璞瑄酒店圆满举办。 本次盛会由天达共和律师事务所品牌运营总监刘思强女士主持,十五佳上榜总法及获奖代表出席了此次盛会。

功承瀛泰落子武汉,拓展华中布局(ZH/EN)

by Charlie Wu 吴卓言 |

总部位于上海的功承瀛泰律师事务所近日正式成立武汉办公室,成为该所在全国范围内的第16家分支机构。